Related Experiment Video
Updated: May 24, 2025

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
Published on: November 4, 2022
A perfused iPSC-derived proximal tubule model for predicting drug-induced kidney injury
Michelle Lechtenberg1, Coraline Chéneau2, Kevin Riquin2
1TissUse GmbH, Berlin, Germany.
Abstract:
The kidney is frequently exposed to high levels of drugs and their metabolites, which can injure the kidney and the proximal tubule (PT) in particular. In order to detect nephrotoxicity early during drug development, relevant in vitro models are essential. Here, we introduce a robust and versatile cell culture insert-based iPSC-derived PT model, which can be maintained in a microphysiological system for at least ten days. We demonstrate the model's ability to predict drug-induced PT injury using polymyxin B, cyclosporin A, and cisplatin, and observe that perfusion distinctly impacts our model's response to xenobiotics. We observe that the upregulation of metallothioneins that is described in vivo after treatment with these drugs is reliably detected in dynamic, but not static in vitro PT models. Finally, we use our model to alleviate polymyxin-induced nephrotoxicity by supplementing the antioxidant curcumin. Together, these findings illustrate that our perfused iPSC-derived PT model is versatile and well-suited for in vitro studies investigating nephrotoxicity and its prevention. Reliable and user-friendly in vitro models like this enable the early detection of nephrotoxic potential, thereby minimizing adverse effects and reducing drug attrition.
Insights
A new kidney proximal tubule model using induced pluripotent stem cells (iPSCs) accurately predicts drug-induced kidney injury. This perfused model helps detect nephrotoxicity early, aiding drug development and prevention strategies.
Area of Science:
- Nephrology
- Toxicology
- Stem Cell Biology
Background:
- Kidneys are susceptible to drug and metabolite toxicity, particularly the proximal tubule (PT).
- Early detection of drug-induced nephrotoxicity requires relevant in vitro models.
- Current models may not fully replicate in vivo conditions for accurate toxicity prediction.
Purpose of the Study:
- To develop and validate a robust, versatile in vitro model of the human proximal tubule using induced pluripotent stem cells (iPSCs).
- To assess the model's capability in predicting drug-induced proximal tubule injury.
- To investigate the impact of perfusion on xenobiotic response and metallothionein upregulation.
Main Methods:
- Established a cell culture insert-based model using iPSC-derived proximal tubule cells.
- Maintained the model in a microphysiological system for up to ten days.
- Utilized perfusion to simulate dynamic physiological conditions and assessed responses to known nephrotoxicants (polymyxin B, cyclosporin A, cisplatin).
Main Results:
- The perfused iPSC-derived PT model successfully predicted drug-induced proximal tubule injury.
- Perfusion significantly influenced the model's response to xenobiotics.
- Upregulation of metallothioneins, a marker of in vivo nephrotoxicity, was detected in the dynamic, perfused model but not in static cultures.
- The model facilitated the investigation of nephrotoxicity prevention, demonstrating curcumin's potential to alleviate polymyxin-induced injury.
Conclusions:
- The perfused iPSC-derived proximal tubule model is a versatile and effective tool for in vitro nephrotoxicity studies.
- This model enables reliable early detection of nephrotoxic potential, supporting safer drug development.
- Dynamic, perfused in vitro systems are crucial for accurately mimicking in vivo responses to nephrotoxic agents and for evaluating protective strategies.
More Related Videos
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Renal Drug Excretion: Tubular Secretion
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Drug Elimination by Renal Route: Tubular Reabsorption
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

